Cancer and Oncology Video Sharing Community

Spotlight
Video

Playlist: Abstract Session


04:43
Thomas Hutson, Memorial Sloan Kettering Cancer Center, New York, NY presents A randomized phase 2 trial of CRLX101 in combination with bevacizumab in patients with metastatic renal cell carcinoma (mRCC) vs standard of care at the 2016 annual International Kidney Cancer Symposium.
by:kidneycancer | 154 views
05:20
Professor Thomas Powles MBBS, MRCP, MD, Barts Cancer Institute presents Clinical outcomes based on MET expression level in METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in advanced renal cell carcinoma (RCC) at the 2016 annual International Kidney Cancer Symposium.
by:kidneycancer | 301 views
04:56
Dylan Martini, MD, Dana-Farber Cancer Institute presents Outcomes in PD-1/PD-L1 inh. responders who discontinued therapy for immune-related adverse events: Analysis of nine patients with metastatic renal cell carcinoma at the 2016 annual International Kidney Cancer Symposium.
by:kidneycancer | 169 views
06:32
James J. Hsieh, MD, PhD, Memorial Sloan Kettering Cancer Center presents Differential Overall Survival Results in RECORD-3 Study Based on Three Distinct Clear Cell Metastatic Renal Cell Carcinoma Molecular Subgroups Classified by BAP1 and/or PBRM1 Mutations at the 2016 annual International Kidney C...
by:kidneycancer | 146 views
04:57
Lana Hamieh, MD, Research Fellow in Medicine (EXT) presents Characterizatio​n of Patients with Poor-Risk Metastatic Renal Cell Carcinoma at the 2016 annual International Kidney Cancer Symposium.
by:kidneycancer | 719 views
04:40
Jun Gong, Fellow, City of Hope presents Latency of potential treatment-relat​ed adverse events among patients treated with TKI/VEGF-direct​ed therapy for metastatic renal cell carcinoma (mRCC) at the 2016 annual International Kidney Cancer Symposium.
by:kidneycancer | 145 views
03:50
Jill Rachel Mains, MD, Dept. of Radiology and Oncology, Aarhus University Hospital presents Baseline Low B-value Diffusion-weigh​ted Magnetic Resonance Imaging is Prognostic in Metastatic Renal Cell Carcinoma and Correlates with Dynamic Contrast-enhanc​ed Ultrasound and Dynamic Contrast-enhanc​ed Com...
by:kidneycancer | 201 views
04:56
Rana McKay, MD, Dana-Farber, presents Impact of Aspirin and Non-Aspirin NSAIDs on Outcomes in Metastatic RCC at the 2016 annual International Kidney Cancer Symposium.
by:kidneycancer | 623 views
04:16
Aly-Khan A. Lalani, Department of Medical Oncology, Cross Cancer Institute, University of Alberta presents Proton Pump Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma (mRCC) at the 2016 annual International Kidney Cancer Symposium.
by:kidneycancer | 388 views
05:08
Chung-Han Lee, MD, PhD, Medical Oncologist, Memorial Sloan Kettering presents Medullary Renal Cell Carcinoma (RCC): Genomics and Treatment Outcomes at the 2016 annual International Kidney Cancer Symposium.
by:kidneycancer | 592 views
Playlist: Abstract Session
Description: Moderators: Andre Fay, Jamie Cajigas
From: kidneycancer
Videos: 12
More playlists from kidneycancer

Playlist URL:
Embed: Embed Code Options